ANTIBODIES BINDING TO HLA-A2/WT1
To provide novel antibodies that bind to HLA-A2/WT1, have markedly useful properties for therapeutic purposes, and include bispecific antibodies.SOLUTION: The present disclosure provides an antibody that binds to HLA-A2/WT1, where the antibody binds to an epitope of HLA A2/WT1, particularly HLA-A2/W...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English Japanese |
Published |
09.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To provide novel antibodies that bind to HLA-A2/WT1, have markedly useful properties for therapeutic purposes, and include bispecific antibodies.SOLUTION: The present disclosure provides an antibody that binds to HLA-A2/WT1, where the antibody binds to an epitope of HLA A2/WT1, particularly HLA-A2/WT1RMF, comprising at least three amino acid residues of the WT1 peptide in HLA-A2/WT1, particularly the WT1RMF peptide.SELECTED DRAWING: None
【課題】HLA−A2/WT1に結合し、治療目的に特に有利な特性を有する、二重特異性抗体を含む新規抗体を提供する。【解決手段】HLA−A2/WT1に結合する抗体であって、抗体は、HLA−A2/WT1のWT1ペプチド、特にWT1RMFペプチドの少なくとも3つのアミノ酸残基を含む、HLA−A2/WT1、特にHLA−A2/WT1RMFのエピトープに結合する抗体。【選択図】なし |
---|---|
Bibliography: | Application Number: JP20210063539 |